Entering into joint venture contracts between Shanghai Zuquan Investment Management Company Limited on one side and Epygon, Kephalios and MyoPowers on the other side.
Recent Posts
- Affluent Medical appoints Liane Teplitsky as a new member of the Board of Directors
- 10th successful human implantation of Artus urinary sphincter, marking completion of the pilot phase
-
Presentation at LSI Europe ’24
Emerging MedTech Summit 2024 (Lisbon)
Sébastien Ladet, CEO -
Interview with Dr. Sarraf
Epygon: A unique device for mitral valve repair - Interview with Michel Therin, Chairman of the Board of Directors and Sébastien Ladet, CEO, in the “Actu Bourse” issue on Boursorama
Recent Comments